Subtopic Deep Dive
GPIHBP1 in Triglyceride Transport
Research Guide
What is GPIHBP1 in Triglyceride Transport?
GPIHBP1 is a glycosylphosphatidylinositol-anchored protein that anchors lipoprotein lipase (LPL) to capillary endothelial cells, enabling lipolysis of triglyceride-rich chylomicrons and VLDL.
GPIHBP1 facilitates LPL transport into capillaries and stabilizes its activity for triglyceride hydrolysis (Beigneux et al., 2007; 457 citations; Davies et al., 2010; 356 citations). Mutations in GPIHBP1 cause hypertriglyceridemia by impairing LPL function. Over 10 papers detail its role in lipid transport.
Why It Matters
GPIHBP1 dysfunction leads to severe hypertriglyceridemia and pancreatitis risk, informing treatments for familial chylomicronemia syndrome (Gaudet et al., 2014; 471 citations). It explains postprandial lipid handling in obesity-related dyslipidemia (Klop et al., 2013; 1603 citations). Understanding GPIHBP1 guides triglyceride-lowering therapies and cardiovascular risk assessment (Berglund et al., 2012; 846 citations).
Key Research Challenges
GPIHBP1 Mutation Effects
Characterizing diverse GPIHBP1 mutations causing hypertriglyceridemia remains incomplete. Functional impacts vary, complicating diagnosis (Beigneux et al., 2007). Targeted studies needed for therapeutic design.
LPL Anchoring Mechanisms
Precise molecular interactions of GPIHBP1 with LPL in capillaries require elucidation (Davies et al., 2010). Nutritional and hormonal regulations add complexity (Kersten, 2014; 535 citations). In vivo models show gaps in dynamic transport.
Therapeutic Targeting
Developing drugs to restore GPIHBP1-LPL function faces delivery challenges to endothelium. APOC3 inhibition aids but bypasses GPIHBP1 directly (Gaudet et al., 2014). Clinical translation limited by rare mutations.
Essential Papers
Dyslipidemia in Obesity: Mechanisms and Potential Targets
Boudewijn Klop, J ELTE, Manuel Castro Cabezas · 2013 · Nutrients · 1.6K citations
Obesity has become a major worldwide health problem. In every single country in the world, the incidence of obesity is rising continuously and therefore, the associated morbidity, mortality and bot...
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Lars Berglund, John D. Brunzell, Anne C. Goldberg et al. · 2012 · The Journal of Clinical Endocrinology & Metabolism · 846 citations
The Task Force recommends that the diagnosis of hypertriglyceridemia be based on fasting levels, that mild and moderate hypertriglyceridemia (triglycerides of 150-999 mg/dl) be diagnosed to aid in ...
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg, Chris J. Packard, M. John Chapman et al. · 2021 · European Heart Journal · 774 citations
Abstract Recent advances in human genetics, together with a large body of epidemiologic, preclinical, and clinical trial results, provide strong support for a causal association between triglycerid...
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
Pratik B. Sandesara, Salim S. Virani, Sergio Fazio et al. · 2018 · Endocrine Reviews · 554 citations
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide. Low-density lipoprotein cholesterol (LDL-C) is a well-established mediator of atherosclerosis and a key ...
Physiological regulation of lipoprotein lipase
Sander Kersten · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 535 citations
Clinical review on triglycerides
Ulrich Laufs, Klaus G. Parhofer, Henry N. Ginsberg et al. · 2019 · European Heart Journal · 507 citations
Abstract Hypertriglyceridaemia is a common clinical problem. Epidemiologic and genetic studies have established that triglyceride-rich lipoproteins (TRL) and their remnants as important contributor...
Coding Variation in <i>ANGPTL4,</i> <i>LPL,</i> and <i>SVEP1</i> and the Risk of Coronary Disease
Nathan O. Stitziel · 2016 · New England Journal of Medicine · 497 citations
We found that carriers of loss-of-function mutations in ANGPTL4 had triglyceride levels that were lower than those among noncarriers; these mutations were also associated with protection from coron...
Reading Guide
Foundational Papers
Start with Beigneux et al. (2007; 457 citations) for GPIHBP1's lipolytic role and Davies et al. (2010; 356 citations) for LPL capillary entry, establishing core mechanisms.
Recent Advances
Study Kersten (2014; 535 citations) for LPL regulation and Gaudet et al. (2014; 471 citations) for therapeutic context in chylomicronemia.
Core Methods
GPIHBP1 studies use knockout mice, genetic sequencing of mutations, lipoprotein fractionation, and immunofluorescence for capillary localization.
How PapersFlow Helps You Research GPIHBP1 in Triglyceride Transport
Discover & Search
Research Agent uses searchPapers and citationGraph to map GPIHBP1-LPL interactions, starting from Beigneux et al. (2007), revealing 356 citing papers like Davies et al. (2010). exaSearch uncovers mutation studies; findSimilarPapers links to Kersten (2014) on LPL regulation.
Analyze & Verify
Analysis Agent applies readPaperContent to extract GPIHBP1 mutation data from Beigneux et al. (2007), then verifyResponse with CoVe checks claims against Berglund et al. (2012) guidelines. runPythonAnalysis with pandas analyzes triglyceride levels across cohorts; GRADE grading scores evidence strength for hypertriglyceridemia risks.
Synthesize & Write
Synthesis Agent detects gaps in GPIHBP1 therapeutics via contradiction flagging between Gaudet et al. (2014) and Klop et al. (2013). Writing Agent uses latexEditText, latexSyncCitations for review manuscripts, and latexCompile for publication-ready figures on LPL pathways; exportMermaid visualizes GPIHBP1 anchoring diagrams.
Use Cases
"Analyze triglyceride levels in GPIHBP1 knockout mouse data from recent papers"
Research Agent → searchPapers('GPIHBP1 knockout triglycerides') → Analysis Agent → readPaperContent(Davies 2010) → runPythonAnalysis(pandas plot levels vs wildtype) → matplotlib graph of lipolysis defects.
"Draft LaTeX review on GPIHBP1 mutations and hypertriglyceridemia"
Synthesis Agent → gap detection(Beigneux 2007, Berglund 2012) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile(PDF with LPL pathway figure).
"Find code for modeling GPIHBP1-LPL binding kinetics"
Research Agent → searchPapers('GPIHBP1 LPL simulation code') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(extract Python kinetics model) → runPythonAnalysis(NumPy simulation of triglyceride hydrolysis).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ GPIHBP1 papers: searchPapers → citationGraph → GRADE all abstracts → structured report on mutation impacts. DeepScan applies 7-step analysis to Beigneux et al. (2007) with CoVe checkpoints for lipolysis claims. Theorizer generates hypotheses on GPIHBP1-APOC3 interactions from Gaudet et al. (2014) and Kersten (2014).
Frequently Asked Questions
What is the definition of GPIHBP1's role?
GPIHBP1 anchors LPL to capillaries for chylomicron triglyceride lipolysis (Beigneux et al., 2007).
What methods study GPIHBP1 function?
Mouse knockouts demonstrate capillary entry defects (Davies et al., 2010); genetic sequencing identifies hypertriglyceridemia mutations.
What are key papers on GPIHBP1?
Beigneux et al. (2007; 457 citations) shows chylomicron processing role; Davies et al. (2010; 356 citations) proves LPL capillary transport.
What open problems exist?
Therapeutics restoring GPIHBP1 function; precise mutation-clinvar correlations; endothelial delivery mechanisms.
Research Lipid metabolism and disorders with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching GPIHBP1 in Triglyceride Transport with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Lipid metabolism and disorders Research Guide